At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
Does this inspire you and feel like a fit? Then we would love to have you join us!
Location:
Europe ( Switzerland) |
Scope:
Europe (EU/EEA/UK/CH as applicable)
Travel:
Up to ~30% (primarily within Europe)
Genmab is focused on the creation and development of innovative, differentiated antibody products to improve the lives of people with cancer.
We are seeking a team-oriented, results-driven professional committed to outstanding collaboration and passionate about strengthening the patient voice in Genmab’s decision-making. The Director/Associate Director, Patient Engagement & Professional Relations (Europe) will lead and advance patient and professional engagement activities across Europe, ensuring the
European patient voice
is meaningfully represented in Genmab’s strategy and decision-making, while partnering closely with global colleagues and alliance partners.
-
European strategy & planning
-
Develop and execute a Europe-wide patient and professional organization engagement strategy aligned with Genmab’s global objectives and adapted to regional and country differences.
-
Act as a strategic partner to cross-functional leaders to ensure patient engagement priorities are integrated across the product lifecycle.
-
External stakeholder engagement (Europe)
-
Build and maintain trusted partnerships with European and country-level patient advocacy groups, umbrella organizations, and professional societies relevant to hematologic malignancies and solid tumors.
-
Represent Genmab in appropriate European forums and at major oncology congresses, collaborating with Medical, Commercial, and Alliance teams.
-
Health Technology Assessment
o Partner cross-functionally with
Market Access/HEOR, Medical Affairs, Regulatory, Value & Evidence, and Commercial
teams to ensure the
European patient voice is appropriately incorporated into HTA strategy and submissions
, where relevant.
o Build and sustain relationships with
European and country-level patient organizations
to support
ethical, compliant, and meaningful inclusion of patient perspectives
in evidence generation and HTA-aligned activities (e.g., patient insights, preference research, PRO strategy, qualitative research, and engagement around value narratives).
o Help translate patient insights into
HTA-relevant outputs
(e.g., unmet need articulation, treatment burden, quality-of-life impacts, caregiver impact, and patient journey insights) and ensure internal teams can use them effectively and compliantly.
o Coordinate (as appropriate)
patient input opportunities
that may support HTA readiness (e.g., advisory boards, structured interviews, workshops) and ensure feedback loops back to participating organizations and internal stakeholders.
o Ensure all HTA-related patient engagement activities align with applicable
European/local requirements, EFPIA and national codes, privacy requirements, and Genmab policies
.
-
Bring the European patient voice into Genmab
-
Identify, design, and deliver innovative approaches to incorporate European patient insights into Genmab decision-making—especially with Medical Affairs, Clinical Development, Regulatory, Market Access/HEOR, Marketing/Commercial, and Alliance colleagues.
-
Translate patient insights into actionable recommendations and ensure feedback loops back to participating organizations and internal stakeholders.
-
Governance, compliance, and privacy (Europe)
-
Ensure all activities align with applicable European and local requirements and industry codes (e.g., EFPIA and relevant national codes), and Genmab policies and procedures.
-
Partner with Legal, Compliance, Medical, and Privacy stakeholders to define appropriate engagement models, contracting, transparency documentation, and reporting.
-
Patient advisory councils & insight forums
-
Oversee and manage internal patient advisory council activities supporting Europe, including:
-
Defining objectives, participant profiles, agendas, pre-reads, and facilitation plans
-
Coordinating approvals and compliance documentation
-
Capturing outcomes through compliant minutes and follow-up reports
-
Tracking action items and ensuring patient input is reflected in cross-functional plans
-
Sponsorships, grants, and congress engagement
-
Coordinate sponsorship and (where applicable) funding/grant processes with patient and professional organizations, ensuring compliant documentation and governance.
-
Plan and support internal patient panels, science days, and meetings with patient and professional organizations at major European congresses.
-
Operational leadership
-
Assist with budgets as assigned, including forecasting and tracking spend against objectives.
-
Contribute to the development and alignment of patient engagement policies, SOPs, and playbooks across Europe.
-
Support other related tasks as assigned.
-
Advanced degree required (MBA, MS, PharmD, PhD, MD, or equivalent).
-
10+ years of experience, including 6+ years in patient engagement/advocacy, stakeholder relations, medical affairs, public affairs, market access, or closely related roles in healthcare/life sciences.
-
Strong understanding of European healthcare systems and policy topics impacting oncology patients (e.g., access, reimbursement, HTA, RWE, patient involvement frameworks), and the ability to navigate country-level differences.
-
Language: Fluency in English required. Additional European languages are a strong advantage.
-
Demonstrated success building and sustaining partnerships with patient and professional organizations across multiple European countries.
-
Strong presentation and facilitation skills; experience running advisory boards and cross-functional sessions.
-
Ability to travel up to ~30% (including occasional overnight/weekend travel), primarily within Europe.
The Team Member We’re Looking For (moved it from under responsibilities)
-
An authentic, innovative, collaborative, and engaging communicator who can build credibility with diverse European stakeholders and internal teams.
-
Strong organizational skills with the ability to manage multiple projects across countries, functions, and timelines.
-
Comfortable interacting with colleagues at all levels and representing Genmab externally.
-
Excellent verbal and written communication; strong facilitation skills for advisory boards and workshops.
-
A genuine passion for social impact and improving outcomes for people living with cancer.
You are genuinely passionate about our purpose
You bring precision and excellence to all that you do
You believe in our rooted-in-science approach to problem-solving
You are a generous collaborator who can work in teams with a broad spectrum of backgrounds
You take pride in enabling the best work of others on the team
You can grapple with the unknown and be innovative
You have experience working in a fast-growing, dynamic company (or a strong desire to)
You work hard and are not afraid to have a little fun while you do so!
Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.
